Aurélie Beaufrère

Aurélie Beaufrère

Auto-generated profile, based on publicly available information

Aurélie Beaufrère

Department of Pathology, APHP-Beaujon Hospital, Université Paris Cité, Paris, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in Histopathology
Verified
Journal Article
Closed access
PDF file
AMAhmed Montasser
Ahmed Montasser
ABAurélie Beaufrère
Aurélie Beaufrère
FCFrançois Cauchy
François Cauchy
MBMohamed Bouattour
Mohamed Bouattour
OSOlivier Soubrane
Olivier Soubrane
VPValérie Paradis
Valérie Paradis

1 June 2021 in Human Pathology
Verified
Journal Article
Closed access
ABAurélie Beaufrère
Aurélie Beaufrère
VPValérie Paradis
Valérie Paradis

1 February 2024 in Radiology
Verified
Journal Article
Closed access
Roberto CannellaRoberto Cannella
Roberto Cannella
FMFrancesco Matteini
Francesco Matteini
MBMarco Dioguardi Burgio
Marco Dioguardi Burgio
RSRiccardo Sartoris
Riccardo Sartoris
ABAurélie Beaufrère
Aurélie Beaufrère
Maxime RonotMaxime Ronot
Maxime Ronot
Background Both Liver Imaging Reporting and Data System (LI-RADS) and histopathologic features provide prognostic information in patients with hepatocellular carcinoma (HCC), but whether LI-RADS is independently associated with survival is uncertain. Purpose To assess the association of LI-RADS categories and features with survival outcomes in patients with solitary resected HCC. Materials and Methods This retrospective study included patients with solitary resected HCC from three institutions examined with preoperative contrast-enhanced CT and/or MRI between January 2008 and December 2019. Three independent readers evaluated the LI-RADS version 2018 categories and features. Histopathologic features including World Health Organization tumor grade, microvascular and macrovascular invasion, satellite nodules, and tumor capsule were recorded. Overall survival and disease-free survival were assessed with Cox regression models. Marginal effects of nontargetoid features on survival were estimated using propensity score matching. Results A total of 360 patients (median age, 64 years [IQR, 56-70 years]; 280 male patients) were included. At CT and MRI, the LI-RADS LR-M category was associated with increased risk of recurrence (CT: hazard ratio [HR] = 1.83 [95% CI: 1.26, 2.66], P = .001; MRI: HR = 2.22 [95% CI: 1.56, 3.16], P < .001) and death (CT: HR = 2.47 [95% CI: 1.72, 3.55], P < .001; MRI: HR = 1.80 [95% CI: 1.32, 2.46], P < .001) independently of histopathologic features. The presence of at least one nontargetoid feature was associated with an increased risk of recurrence (CT: HR = 1.80 [95% CI: 1.36, 2.38], P < .001; MRI: HR = 1.93 [95% CI: 1.81, 2.06], P < .001) and death (CT: HR = 1.51 [95% CI: 1.10, 2.07], P < .010) independently of histopathologic features. In matched samples, recurrence was associated with the presence of at least one nontargetoid feature at CT (HR = 2.06 [95% CI: 1.15, 3.66]; P = .02) or MRI (HR = 1.79 [95% CI: 1.01, 3.20]; P = .048). Conclusion In patients with solitary resected HCC, LR-M category and nontargetoid features were negatively associated with survival independently of histopathologic characteristics. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Kartalis and Grigoriadis in this issue.

21 January 2024 in JHEP Reports
Verified
Journal Article
Open access
ABAurélie Beaufrère
Aurélie Beaufrère
NONora Ouzir
Nora Ouzir
PZPaul Emile Zafar
Paul Emile Zafar
ALAstrid Laurent-Bellue
Astrid Laurent-Bellue
MAMiguel ALBUQUERQUE
Miguel ALBUQUERQUE
VPValérie Paradis
Valérie Paradis
The diagnosis of primary liver cancers (PLCs) can be challenging, especially on biopsies and for combined hepatocellular-cholangiocarcinoma (cHCC-CCA). We automatically classified PLCs on routine-stained biopsies using a weakly supervised learning method. We selected 166 PLC biopsies divided into training, internal and external validation sets: 90, 29 and 47 samples, respectively. Two liver pathologists reviewed each whole-slide hematein eosin saffron (HES)-stained image (WSI). After annotating the tumour/non-tumour areas, tiles of 256x256 pixels were extracted from the WSIs and used to train a ResNet18 neural network. The tumour/non-tumour annotations served as labels during training, and the network's last convolutional layer was used to extract new tumour tile features. Without knowledge of the precise labels of the malignancies, we then applied an unsupervised clustering algorithm. Pathological review classified the training and validation sets into hepatocellular carcinoma (HCC, 33/90, 11/29 and 26/47), intrahepatic cholangiocarcinoma (iCCA, 28/90, 9/29 and 15/47), and cHCC-CCA (29/90, 9/29 and 6/47). In the two-cluster model, Clusters 0 and 1 contained mainly HCC and iCCA histological features. The diagnostic agreement between the pathological diagnosis and the two-cluster model predictions (major contingent) in the internal and external validation sets was 100% (11/11) and 96% (25/26) for HCC and 78% (7/9) and 87% (13/15) for iCCA, respectively. For cHCC-CCA, we observed a highly variable proportion of tiles from each cluster (cluster 0: 5-97%; cluster 1: 2-94%). Our method applied to PLC HES biopsy could identify specific morphological features of HCC and iCCA. Although no specific features of cHCC-CCA were recognized, assessing the proportion of HCC and iCCA tiles within a slide could facilitate the identification of cHCC-CCA. The diagnosis of primary liver cancers can be challenging, especially on biopsies and for combined hepatocellular-cholangiocarcinoma (cHCC-CCA). We automatically classified primary liver cancers on routine-stained biopsies using a weakly supervised learning method. Our model identified specific features of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Despite no specific features of cHCC-CCA being recognized, the identification of hepatocellular carcinoma and intrahepatic cholangiocarcinoma tiles within a slide could facilitate the diagnosis of primary liver cancers, and particularly cHCC-CCA.

1 April 2021 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
HCHélène Céruti
Hélène Céruti
GKGilles Kayem
Gilles Kayem
LGLucie Guilbaud
Lucie Guilbaud
CDChloé Dussaux
Chloé Dussaux
AGAnne Gervais
Anne Gervais
Emeline MaisonneuveEmeline Maisonneuve
Emeline Maisonneuve

1 November 2024 in Radiology
Verified
Journal Article
Closed access
HJHanyu Jiang
Hanyu Jiang
Roberto CannellaRoberto Cannella
Roberto Cannella
ZWZhenru Wu
Zhenru Wu
ABAurélie Beaufrère
Aurélie Beaufrère
MBMarco Dioguardi Burgio
Marco Dioguardi Burgio
Maxime RonotMaxime Ronot
Maxime Ronot
In general, MRI-assessed intratumoral fat was nonprognostic, but homogeneous intratumoral fat was associated with longer recurrence-free survival and overall survival in an Asian cohort of patients with hepatocellular carcinoma.